Tomoyuki Nagai

FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma

Tokuzo Arao, Kazuomi Ueshima, Kazuko Matsumoto et al. · Hepatology · 2012 · 153 citations · Full text

Medicine, Molecular Biology, Oncology +15

Age-related alteration in the activities of drug-metabolizing enzymes and contents of sex-specific forms of cytochrome P-450 in liver microsomes from male and female rats.

Tetsuya Kamataki, Kazutaka Maeda, Masayuki Shimada et al. · Journal of Pharmacology and Experimental Therapeutics · 1985 · 152 citations

Medicine, Biochemistry, Pharmacology +15

Sorafenib Inhibits the Hepatocyte Growth Factor–Mediated Epithelial Mesenchymal Transition in Hepatocellular Carcinoma

Tomoyuki Nagai, Tokuzo Arao, Kazuyuki Furuta et al. · Molecular Cancer Therapeutics · 2011 · 120 citations · Full text

Medicine, Oncology, Pharmacology +17

Highly Sensitive Detection of EGFR T790M Mutation Using Colony Hybridization Predicts Favorable Prognosis of Patients with Lung Cancer Harboring Activating EGFR Mutation

Yoshihiko Fujita, Kenichi Suda, Hideharu Kimura et al. · Journal of Thoracic Oncology · 2012 · 118 citations · Full text

Medicine, Genetics, Oncology +12

Activin A inhibits vascular endothelial cell growth and suppresses tumour angiogenesis in gastric cancer

Hiroyasu Kaneda, Tokuzo Arao, Kunio Matsumoto et al. · British Journal of Cancer · 2011 · 111 citations · Full text

Life Sciences, Molecular Biology, Oncology +10